Intellia Therapeutics, Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Social & Marketing
Video & Media
Email & Communication
Keywords & Focus Areas
Intellia Therapeutics, Inc.
Overview
Intellia Therapeutics, Inc. is a clinical-stage biotechnology company based in Cambridge, Massachusetts. The company focuses on developing genome editing therapeutics using CRISPR/Cas9 technology to address severe diseases, and is recognized for pioneering work in in vivo CRISPR-based treatments, delivering gene-editing components directly into the body, particularly targeting the liver for single-dose therapies.
With a mission to transform the lives of individuals with severe diseases by creating potentially curative treatments, Intellia has advanced a key asset, Lonvo-z (formerly NTLA-2002), aiming to provide a single-dose functional cure for hereditary angioedema. The company emphasizes leadership in systemic in vivo delivery methods and patient-centric innovation, strategically focusing its development pipeline on high-value candidates. Intellia is led by experienced management and a board with extensive biotech expertise.
Basic Information
| Industry | research |
|---|---|
| Founded | 2014 |
| Revenue | 57.9M |
| Headquarters | 40 Erie Street, Cambridge, Massachusetts 02139, United States |
| Languages | English |
| Alexa Ranking |
Contact Details
- Phone: +1 857-285-6200
- Website: intelliatx.com
- LinkedIn: linkedin.com/company/intelliatx
Key Focus Areas & Initiatives
- Biotechnology research
- CRISPR-based medicines
- Genomic medicines
- Gene editing pipeline development
- Gene editing research
- Rare disease treatment
- Therapeutic pipeline
- Gene editing in vivo
- Gene editing treatments
- Gene editing for cancer
- Autoimmune diseases
- Ex vivo therapy
- Cell therapies
- Biotech innovation
- Genetic diseases
- Gene editing leadership
- Gene editing for genetic disorders
- Gene editing in biotech
- Gene editing therapeutics
- Genome editing technology
- In vivo therapy
- Clinical-stage biotech
- Pharmaceuticals
- Gene editing patent portfolio
- Research and development in the physical, engineering, and life sciences
- Oncology
- Gene correction
- Therapeutic development
- Clinical trials
- Disease treatment
- Precision medicine
- Next-generation therapies
- Medical treatments
- Healthcare initiatives
Technologies Used
- AI
- Adobe Marketing Cloud
- Circle
- ConvertCart
- Crisp
- DNS Made Easy
- Drupal
- E-planning
- Google AdWords Conversion
- Google Tag Manager
- Hotjar
- Microsoft Dynamics 365 Supply Chain Management
- Microsoft Excel
- Microsoft Office 365
- Microsoft PowerPoint
- Mimecast
- Mobile Friendly
- Oracle Cloud
- Oracle Fusion
- Outlook
- Remote
- Salesforce CRM Analytics
- Semrush
- Slack
- Veeva CRM
- Vimeo
- WP Engine
- WordPress.org
- Zoomdata
Community
